87 related articles for article (PubMed ID: 3141525)
1. [Trends of fluoroquinolone-resistant strains isolated from clinical materials].
Konno M; Ohonari S; Itoh N; Ubukata K; Hashimoto Y; Kawakami S
Kansenshogaku Zasshi; 1988 Jul; 62(7):641-51. PubMed ID: 3141525
[No Abstract] [Full Text] [Related]
2. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
[TBL] [Abstract][Full Text] [Related]
4. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
5. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Rahal K
Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
[TBL] [Abstract][Full Text] [Related]
6. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
Lafredo SC; Foleno BD; Fu KP
Chemotherapy; 1993; 39(1):36-9. PubMed ID: 8383031
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteria.
Cormican MG; Jones RN
J Antimicrob Chemother; 1995 Aug; 36(2):431-4. PubMed ID: 8522474
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
10. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Kowalski RP; Pandya AN; Karenchak LM; Romanowski EG; Husted RC; Ritterband DC; Shah MK; Gordon YJ
Ophthalmology; 2001 Oct; 108(10):1826-9. PubMed ID: 11581056
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.
Gaillot O; Berche P
Drugs; 1995; 49 Suppl 2():200-2. PubMed ID: 8549303
[No Abstract] [Full Text] [Related]
12. In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens.
Eiferman RA
Cornea; 2001 May; 20(4):438-9. PubMed ID: 11333340
[No Abstract] [Full Text] [Related]
13. [In vitro development of fluoroquinolone resistance in the glanders pathogen].
Stepanshin IuG; Manzeniuk IN; Svetoch EA; Volkovoĭ KI
Antibiot Khimioter; 1994 Aug; 39(8):30-3. PubMed ID: 7695437
[TBL] [Abstract][Full Text] [Related]
14. In vitro comparison of ciprofloxacin, ofloxacin, and povidone-iodine for surgical prophylaxis.
Keverline MR; Kowalski RP; Dhaliwal DK
J Cataract Refract Surg; 2002 Jun; 28(6):915-6. PubMed ID: 12036617
[No Abstract] [Full Text] [Related]
15. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
Aeschlimann JR; Kaatz GW; Rybak MJ
J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
[TBL] [Abstract][Full Text] [Related]
16. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
Becnel Boyd L; Maynard MJ; Morgan-Linnell SK; Horton LB; Sucgang R; Hamill RJ; Jimenez JR; Versalovic J; Steffen D; Zechiedrich L
Antimicrob Agents Chemother; 2009 Jan; 53(1):229-34. PubMed ID: 18838594
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ciprofloxacin, norfloxacin, and ofloxacin against multi-resistant Enterobacteriaceae.
Niculescu E; Wagener H
Chemioterapia; 1987 Jun; 6(2 Suppl):132-3. PubMed ID: 3509369
[No Abstract] [Full Text] [Related]
18. High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
Tanaka M; Kumazawa J; Matsumoto T; Kobayashi I
Genitourin Med; 1994 Apr; 70(2):90-3. PubMed ID: 8206482
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone derivatives: effects on neutrophil functional tests.
Bersani C; Santagada T; Bertoletti R; Fietta A; Gialdroni Grassi G
Chemioterapia; 1987 Jun; 6(2 Suppl):222-3. PubMed ID: 3334562
[No Abstract] [Full Text] [Related]
20. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. b. Synthetic antibacterial agents].
Ohno I; Ida S
Nihon Rinsho; 1987 Mar; 45(3):577-82. PubMed ID: 3298736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
